Company Scope Fluidics S.A.

Stocks

SCP

PLSCPFL00018

Biotechnology & Medical Research

Market Closed - Warsaw S.E. 16:20:00 16/10/2026 BST			5-day change	1st Jan Change
134.00 ^PLN	+0.90%		+4.04%	-1.62%

09-30	Scope Fluidics S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-27	Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip'	RE

Business description: Scope Fluidics S.A.

Scope Fluidics SA is a Poland-based company engaged in the biotechnology. The Company focuses on diagnostic and med-tech solutions. It develops disposable microfluidic systems for the collection of micro-samples of blood, as well as storage of reagents for diagnostic markers. Its projects include PCR ONE system that delivers the bacterial and viral pathogen detection, and BacterOMIC system that delivers information on bacterial susceptibility to antibiotics and on the resistance mechanisms. The Company provides access to laboratories and workshops for developed projects, as well as administrative facilities and services, including financing. In addition, it cooperates with doctors, medical personnel, project managers, engineers and academics.

Number of employees: 175

Sales by Activity: Scope Fluidics S.A.

Fiscal Period: December	2021 (PLN)	2022 (PLN)	2023 (PLN)	2024 (PLN)	2025 (PLN)
Innovations in The Field of Diagnostics and Health Protection	-	404K	516K	131K	100K

See all business segments

Geographical breakdown of sales: Scope Fluidics S.A.

Fiscal Period: December	2021 (PLN)	2022 (PLN)	2023 (PLN)	2024 (PLN)	2025 (PLN)
Poland	-	404K	516K	131K	100K

See all geographic segments

Executive Committee: Scope Fluidics S.A.

Manager	Title	Age	Since
Marcin Izydorzak PRN	Corporate Officer/Principal	52	-
Piotr Garstecki CEO	Chief Executive Officer	51	-
Szymon Ruta DFI	Director of Finance/CFO	50	-
Anna Siemianowska ADM	Chief Administrative Officer	-	31/12/2010
Maja Czerwinska IRC	Investor Relations Contact	-	31/12/2020

See SCOPE FLUIDICS S.A. governance

Composition of the Board of Directors: Scope Fluidics S.A.

Director	Title	Age	Since
Robert Boguslaw Przytula CHM	Chairman	51	06/03/2017
Andrzej Chadzynski BRD	Director/Board Member	50	06/03/2017
Robert Piotr Holyst BRD	Director/Board Member	63	06/03/2017
Patryk Mikucki BRD	Director/Board Member	51	28/06/2018
Karolina Radziszewska BRD	Director/Board Member	51	-
Joanna Rzempala BRD	Director/Board Member	-	28/02/2022

Composition of the Board of Directors

Shareholders: Scope Fluidics S.A.

Name	Stocks	%	Valuation
IPOPEMA TFI SA 19.21 %	608,496	19.21 %	19 M zł
Piotr Garstecki 11.6 %	367,674	11.6 %	12 M zł
Marcin Izydorzak 11.24 %	356,223	11.24 %	11 M zł

List of SCOPE FLUIDICS S.A. shareholders

Company details: Scope Fluidics S.A.

Scope Fluidics SA

ul. Ogrodowa 58

00-876, Warsaw

+48 22 376 2114

http://www.scopefluidics.com

Bio Diagnostics & Testing

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SCOPE FLUIDICS S.A.	+0.90%	+4.04%	-24.29%	-18.29%	109M
WUXI APPTEC CO., LTD.	-6.60%	-10.93%	+45.08%	+60.01%	68.98B
ARGENX SE	-4.09%	+3.12%	+3.71%	+53.50%	53.15B
LONZA GROUP AG	+0.03%	+7.21%	+12.52%	+44.46%	50.83B
IQVIA HOLDINGS INC.	-1.53%	+3.10%	+31.40%	+33.88%	44.61B
REVOLUTION MEDICINES, INC.	-5.97%	-5.40%	+259.08%	+494.98%	40.57B
BEONE MEDICINES AG	-1.34%	+5.41%	+16.74%	+106.42%	42.53B
CELLTRION, INC.	+6.53%	+8.02%	+18.98%	+54.58%	30.95B
WUXI BIOLOGICS (CAYMAN) INC.	-0.90%	-10.91%	+34.11%	-1.83%	25.44B
BIONTECH SE	-2.76%	-4.73%	-15.94%	-15.32%	22.66B
Average	-1.39%	+1.82%	+38.14%	+81.24%	37.98B
Weighted average by Cap.	-2.32%	+1.65%	+46.49%	+96.50%